Complications following the intra-amniotic administration of prostaglandin f-2-alpha for therapeutic abortion.
D000028:Abortion, Induced; D000328:Adult; D001919:Bradycardia / Q000139:chemically induced* / Q000188:drug therapy; D002584:Cervix Uteri / Q000293:injuries; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000188:drug therapy; D007035:Hypothermia / Q000139:chemically induced* / Q000188:drug therapy; D007263:Infusions, Parenteral; D008614:Meperidine / Q000627:therapeutic use; D010121:Oxytocin / Q000627:therapeutic use; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D012421:Rupture / Q000209:etiology; D013268:Stimulation, Chemical; D014599:Uterus / Q000187:drug effects
D011453:Prostaglandins; D010121:Oxytocin; D008614:Meperidine